“These findings indicate that standardized efficacy, safety, and risk assessment reporting remains inadequate for FDA-cleared AI/ML devices, underscoring the need for dedicated regulatory pathways and robust postmarket surveillance to ensure patient safety."
Given the high mortality associated with gastric variceal hemorrhage, ongoing investigation into pharmacologic and interventional approaches remains critical to improving patient outcomes.
Largest contemporary randomized trial demonstrates benefit following myocardial infarction in patients with preserved or mildly reduced ejection fraction.
Testimony from former CDC leadership highlighted differences with federal health officials on the process for reviewing and implementing vaccine policies.